|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
6R44CA156740-05
|
$999,919
|
RHODE, PETER
|
ALTOR BIOSCIENCE. LLC
|
|
Novel Biomarkers for the Clinical Management of Bladder Cancer
|
1R01CA227277-01A1
|
$466,211
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer
|
1R44CA232963-01
|
$299,937
|
GLODE, MIKE
|
AURORA ONCOLOGY, INC.
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
3R01CA175397-05S1
|
$110,950
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers
|
1R01CA216426-01A1
|
$427,819
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer
|
5R01CA220297-02
|
$365,246
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-05
|
$1,187,291
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Patient-Centered Approach to Integration of Life Expectancy into Treatment Decision Making for Patients with Genitourinary Malignancy
|
1K08CA230155-01
|
$183,258
|
DASKIVICH, TIMOTHY
|
CEDARS-SINAI MEDICAL CENTER
|
|
Bladder Fiducial Markers and Diffusion-MRI to Optimize Bladder Chemo-Radiotherapy
|
5R01CA201709-03
|
$724,638
|
GARCIA, MAURICE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
3R01CA143971-08S1
|
$149,644
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Regulation and Targeting of CD24 in Bladder Cancer
|
7R01CA075115-20
|
$357,944
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
7R01CA143971-08
|
$481,438
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-04
|
$474,774
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
|
5U01CA217858-02
|
$1,314,469
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S1
|
$120,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S2
|
$60,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant - PDXNet Supplement
|
3P30CA013696-44S3
|
$126,563
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S4
|
$191,726
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S5
|
$237,191
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S6
|
$246,815
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S7
|
$224,982
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S8
|
$126,563
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-44
|
$3,972,720
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
IGF::OT::IGF SEER-LINKED VIRTUAL TISSUE REPOSITORY PERIOD OF PERFORMANCE: 09/11/2015 - 03/31/2019
|
261201300019I
|
$3,920
|
MUELLER, LLOYD
|
CONNECTICUT STATE DEPT OF PUBLIC HEALTH
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
ECOG-ACRIN Network Group Statistics and Data Management Center
|
5U10CA180794-05
|
$7,856,253
|
GRAY, ROBERT
|
DANA-FARBER CANCER INST
|
|
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
|
5K08CA219504-02
|
$177,120
|
MOUW, KENT
|
DANA-FARBER CANCER INST
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
5R01CA216265-02
|
$602,394
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-05
|
$357,057
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S1
|
$100,606
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S2
|
$127,198
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S3
|
$112,196
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S4
|
$67,481
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S5
|
$35,000
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-39
|
$3,139,824
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-05
|
$413,627
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-05S1
|
$702,581
|
ODWYER, PETER
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
5U10CA180820-05
|
$12,090,503
|
ODWYER, PETER
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
IGF::OT::IGF EQUITABLE ADJUSTMENT FOR CHANGE ORDER.
|
261201300015I
|
$45,431
|
WARD, KEVIN
|
EMORY UNIVERSITY
|
|
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
|
1R01CA224918-01A1
|
$722,281
|
DIEFENBACH, MICHAEL
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|